Skip to content

Repetitive transcranial magnetic stimulation for the treatment of post-stroke fatigue:a randomized double-blind controlled pilot study

Repetitive transcranial magnetic stimulation for the treatment of post-stroke fatigue:a randomized double-blind controlled pilot study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076431
Enrollment
Unknown
Registered
2023-10-08
Start date
2023-10-30
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke fatigue

Interventions

treatment group:Repetitive transcranial stimulation therapy
control group:Shame stimulation therapy

Sponsors

The First Affiliated hospital of USTC
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Age = 18 years 2) Clinical criteria: (1) First stroke episode within 90d ± 30d (2) FSS scale score =36 within 2 weeks of stroke onset (3) FSS scale score = 36 before rTMS treatment (4) Signed informed consent form

Exclusion criteria

Exclusion criteria: 1) Infarct lesions accumulate in the cerebral cortex 2) mRS > 2 points 3) recurrent cerebrovascular events during the screening period 4) Use of centrally acting drugs that may affect fatigue, depression and anxiety levels during the screening period, such as reserpine, fluoxetine, paroxetine, sertraline, citalopram, fluvoxamine benzodiazepines, hormones, etc. 5) Change in NIHSS score score <0 (indicating neurological deterioration) from the start of the screening period to the end of the screening period 6) Severe dementia or impaired consciousness, unable to complete scale related tests 7) Concomitant stroke with other neurological related disorders or psychiatric related severe disorders (including schizophrenia, severe cognitive impairment, multiple sclerosis, Parkinson's syndrome, traumatic brain injury, epilepsy, cerebral oedema, etc.) 8) Patients with cumulative pre- and post-stroke circulation 9) Pregnant and lactating women 10) Claustrophobia 11)Metallic foreign bodies such as pacemakers in the body

Design outcomes

Primary

MeasureTime frame
fatigue severity scale;

Secondary

MeasureTime frame
Apathy Evaluation Scale;Hamilton Anxiety Scale;Hamilton Depression Scale;Montreal Cognitive Assessment;Health-Related Quality of Life;National Institute of Health stroke scale;Modified Rankin Scale;

Countries

China

Contacts

Public ContactWen Sun

Cerebrovascular Disease Center / Department of Neurology, the First Affiliated Hospital of University of Science and Technology of China

sunwen_neuro@fsyy.ustc.edu.cn+86 150 5058 9620

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026